Regeneron Pharmaceuticals shares owned by Desjardins Global Asset Management
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Desjardins Global Asset Management
from 13F filings
Historical chart of Desjardins Global Asset Management investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Desjardins Global Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Desjardins Global Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $767k | 873 | 878.15 |
| 2023-09-30 | $1.1M | 1.4k | 822.91 |
| 2023-06-30 | $1.6M | 2.2k | 718.54 |
| 2023-03-31 | $2.3M | 2.7k | 821.56 |
| 2022-12-31 | $2.7M | 3.7k | 721.26 |
| 2022-09-30 | $3.4M | 4.9k | 688.72 |
| 2022-06-30 | $2.9M | 4.9k | 591.02 |
| 2022-03-31 | $4.0M | 5.8k | 698.32 |
| 2021-12-31 | $5.9M | 9.4k | 631.43 |
More positions owned by Desjardins Global Asset Management
View all positions for Desjardins Global Asset Management